Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancers with loss of chromosome 16Q and/or low expression of metallothionein proteins

Cancers with loss of chromosome 16Q and/or low expression of metallothionein proteins

US Patent 12435377 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
Tepoxalin targeting of ABCB1 overexpressing cancers2025
DNA damage response signature guided rational design of CRISPR-based systems and2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Agents for reversing toxic proteinopathies2024
Agents for reversing toxic proteinopathies2024